Risk of potential drug-drug interactions among brazilian elderly: A population-based, cross-sectional study

Drugs and Aging

Volumn 27, Issue 9, 2010, Pages 759-770

  Secoli, Silvia Regina ^a   Figueras, Albert ^b   Lebro, Maria Lúcia ^a   De Lima, Ferno Dias ^a   Santos, Jair Licio Ferreira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Drug interactions; Elderly

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORPROPAMIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ADULT; AGED; AGING; ARTICLE; BRAZIL; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GERIATRICS; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEALTH SURVEY; HEART DISEASE; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLYPHARMACY; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; WELLBEING;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRAZIL; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 77956304286     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11538460-000000000-00000     Document Type: Article

References (42)

1. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27: 832-839
2. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. JAMA 1997; 277: 301-306
3. Hohl CM, Dankoff J, Colacone A, et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38: 666-671
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 200-205
5. Tato DS. Drug interactions facts. Saint Louis (MO): Facts and Comparisons, 2002
6. Bachmann KA. Drug interactions handbook. Hudson (OH): Lexi, 2003
7. Grahame-Smith DG, Aronson JK. Drug interactions. In: Grahame-Smith DG, Aronson JK. Oxford textbook of clinical pharmacology and drug therapy. Oxford: Oxford University Press, 2002: 105-118
8. Secoli SR. Drug interactions: fundamental aspects for clinical practice nursing. Rev Esc Enferm USP 2001; 35: 28-34
9. Fonseca RB, Secoli SR. Drugs used in bone marrow transplantation: a study about combinations of antimicrobial potentially interactives. Rev Esc Enferm USP 2008; 42: 706-714
10. Spitzer WO. Drug as determinants of health and disease in the population: an orientation to the bridge of pharmacoepidemiology. J Clin Epidemiol 1991; 44: 823-830
11. Prybys KM, Melville K, Hanna J, et al. Polypharmacy in the elderly - clinical challenges in emergency practice: part 1. Overview, etiology, and drug interactions. Emerg Med Rep 2002; 23: 145-153
12. Bjorkman IK, Fastbom J, Schmidt IK, et al., The Pharmaceutical Care of the Elderly in Europe Research (PEER) Group. Drug-drug interactions in the elderly. Ann Pharmacother 2002; 36: 1675-1681
13. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767-777
14. Egger SS, Jurgen D, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 2004; 58: 773-778
15. Schneider JK, Mion LC, Frengley JD. Adverse drug reactions in an elderly outpatient population. Am J Hosp Pharm 1992; 49: 90-96
16. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36: 1331-1336
17. Langdorf M, Fox J, Marwah R, et al. Physician versus computer knowledge of potential drug interactions in the emergency department. Acad Emerg Med 2000; 7: 1321-1329
18. Gaddi G, Holt T, Woods M. Drug interactions in at risk emergency department patients. Acad EmergMed 2002; 9: 1162-1167
19. Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatric Soc 1996; 44: 944-948
20. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997; 157: 2089-2096
21. Lebr ão ML, Laurenti R. Health, well-being and aging: the SABE study in S ão Paulo, Brazil. Rev Bras Epidemiol 2005; 8: 127-141
22. World Health Organization. Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs); Geneva, 2007 (updated on 2006 Dec 16) [online]. Available from URL: http://www.whocc.no/atcddd/ index[Accessed 2007 Mar 16]
23. Micromedex® Healthcare Series. Greenwood Village (CO): Thomson Reuters (Healthcare) Inc., 2007 [online]. Available from URL: https://www.thomsonhc.com/hcs/librarian/ [Accessed 2005 Sep 5]
24. Costa AJ. Potential drug interactions in an ambulatory geriatric population. Fam Pract 1991; 8: 234-236
25. Bergendal L, Friberg A, Schaffrath AM. Potential drugdrug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden. Pharm World Sci 1995; 17: 152-157
26. Gaeta TJ, Fiorini M, Ender K, et al. Potential drug-drug interactions in elderly patients presenting with syncope. J Emerg Med 2002; 22: 159-162
27. Aparasu R, Baer R, Aparasu A. Clinically important potential drug-drug interactions in outpatient settings. Res Soc Administrat Pharm 2007; 3: 426-437
28. Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003; 48: 133-143
29. Karas Jr S. The potential for drug interactions. Ann Emerg Med 1981; 10: 627-630
30. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch InternMed 1995; 155: 1949-1956
31. Thomas A, Routledge PA. Drug interaction in clinical practice. Focus Pharmacovigilance Bull 2003: 1-7
32. Seymour RM, Routledge PA. Important drug-drug interactions the elderly. Drugs Aging 1998; 12: 485-494
33. Anderson JR, Nawarskas JJ. Cardiovascular drug-drug interactions. Cardiol Clin 2001; 19: 215-234
34. Ament PW, Bertolino JG, Liszewski JL. Clinically significant drug interactions. Am Fam Physician 2000; 61: 1745-1754
35. Oscanoa T. Interaction medicamentosa em geriatría. An Facultad Medic 2006; 2: 119-126
36. Romero R, Castellote E, Ocon J, et al. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension. J Cardiovasc Pharmacol 1995; 26: 114-118
37. Mahe I, Meune C, Diemer M, et al. Interaction between aspirin and ACE inhibitors in patients with heart failure. Drug Saf 2001; 24: 167-182
38. Malone DC, Hutchins DS, Haupert H, et al. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm 2005; 62: 1983-1991
39. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005; 165: 1095-1106
40. Chung L, Chakravarty EF, Kearns P, et al. Bleeding complications in patients on celecoxib and warfarin. J Clin Pharm Ther 2005; 30: 471-477
41. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652-1658
42. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007; 370: 185-191